Please login to the form below

Not currently logged in
Email:
Password:

The Harmony Alliance gathers to battle blood cancer

Uses its big data platform to analyse the disease

blood cellsAt the 2nd general assembly based in Berlin, Germany last week, 120 representatives from the Innovative Medicines Initiative’s (IMI) Harmony Alliance all gathered to discuss achievements and objectives surrounding blood cancer.

The alliance, which brings together 51 partners and key stakeholders from eleven European countries, uses its big data platform to better understand blood cancer and contribute to improving targeted therapies.

Michel Van Speybroeck, director of data sciences, Janssen, said: “Public and private partners are bringing together their best people, data and knowledge to solve key questions on haematological cancers.

“These challenges can only be met by applying the most advanced technology and it’s wonderful to see from the front-line how this is being shaped by the Harmony Alliance.”

The alliance aims to offer an ethical and legal framework on the use of medical data, using its new platform for analysis and defining “standard sets of outcomes”.

Article by
Gemma Jones

30th October 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics